128 related articles for article (PubMed ID: 15135549)
1. The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials.
Mooney M; White T; Hatsukami D
Addict Behav; 2004 Jun; 29(4):673-84. PubMed ID: 15135549
[TBL] [Abstract][Full Text] [Related]
2. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
[TBL] [Abstract][Full Text] [Related]
5. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women.
Cepeda-Benito A; Reynoso JT; Erath S
J Consult Clin Psychol; 2004 Aug; 72(4):712-22. PubMed ID: 15301656
[TBL] [Abstract][Full Text] [Related]
8. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
[TBL] [Abstract][Full Text] [Related]
9. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
Shiffman S; Ferguson SG; Strahs KR
Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
[TBL] [Abstract][Full Text] [Related]
10. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
[TBL] [Abstract][Full Text] [Related]
11. Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness.
Walsh RA
Drug Alcohol Rev; 2008 Sep; 27(5):529-47. PubMed ID: 18696300
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
Becker KM; Rose JE; Albino AP
Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
[TBL] [Abstract][Full Text] [Related]
13. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Lam S; Patel PN
Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
[TBL] [Abstract][Full Text] [Related]
14. Nicotine replacement therapy.
Nurs Times; 2005 Mar 1-7; 101(9):32. PubMed ID: 15783156
[No Abstract] [Full Text] [Related]
15. The use of the nicotine inhaler in smoking cessation.
Burkett JS
J Am Acad Nurse Pract; 2006 Mar; 18(3):83-91. PubMed ID: 16499741
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Cinciripini PM; Tsoh JY; Wetter DW; Lam C; de Moor C; Cinciripini L; Baile W; Anderson C; Minna JD
Exp Clin Psychopharmacol; 2005 Nov; 13(4):282-92. PubMed ID: 16366758
[TBL] [Abstract][Full Text] [Related]
17. Industry funding and placebo quit rate in clinical trials of nicotine replacement therapy: a commentary on Etter et al. (2007).
Greene NM; Taylor EM; Gage SH; Munafò MR
Addiction; 2010 Dec; 105(12):2217-8; author reply 2219. PubMed ID: 21054610
[No Abstract] [Full Text] [Related]
18. Smoking cessation trials.
Polito JR
CMAJ; 2008 Nov; 179(10):1037-8; author reply 138. PubMed ID: 18981448
[No Abstract] [Full Text] [Related]
19. Nicotine substitutes and pregnancy.
Prescrire Int; 2001 Aug; 10(54):116-7. PubMed ID: 11718181
[TBL] [Abstract][Full Text] [Related]
20. When California smokers use nicotine replacement therapy, most are trying to quit smoking.
Al-Delaimy WK; Gilpin EA; Pierce JP
Tob Control; 2005 Oct; 14(5):359-60. PubMed ID: 16183988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
